News coverage about Quorum Health Corporation (NYSE:QHC) has trended somewhat positive on Thursday, Accern reports. Accern rates the sentiment of press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Quorum Health Corporation earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned press coverage about the company an impact score of 45.4544396761321 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Quorum Health Corporation (NYSE:QHC) traded up 2.32% during mid-day trading on Thursday, hitting $4.85. The stock had a trading volume of 64,174 shares. The stock’s 50 day moving average price is $4.84 and its 200 day moving average price is $4.84. Quorum Health Corporation has a one year low of $2.54 and a one year high of $9.46. The firm’s market capitalization is $146.94 million.

Quorum Health Corporation (NYSE:QHC) last released its quarterly earnings results on Wednesday, August 9th. The company reported ($0.42) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.66) by $0.24. The business had revenue of $530.15 million during the quarter, compared to analysts’ expectations of $513.50 million. Quorum Health Corporation had a negative return on equity of 26.69% and a negative net margin of 6.88%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period last year, the firm posted ($0.82) EPS. Analysts forecast that Quorum Health Corporation will post ($1.55) EPS for the current year.

QHC has been the subject of a number of research analyst reports. Zacks Investment Research upgraded Quorum Health Corporation from a “hold” rating to a “buy” rating and set a $4.50 price target for the company in a report on Saturday, July 22nd. Credit Suisse Group boosted their price objective on Quorum Health Corporation from $3.00 to $4.00 and gave the company a “neutral” rating in a research report on Monday, August 14th. Deutsche Bank AG boosted their price objective on Quorum Health Corporation from $3.00 to $3.50 and gave the company a “hold” rating in a research report on Monday, August 14th. ValuEngine upgraded Quorum Health Corporation from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Finally, Royal Bank Of Canada restated a “hold” rating and set a $5.00 price objective on shares of Quorum Health Corporation in a research report on Tuesday, October 3rd. Three analysts have rated the stock with a sell rating and four have assigned a hold rating to the stock. The company presently has an average rating of “Hold” and an average price target of $4.13.

COPYRIGHT VIOLATION WARNING: This article was first posted by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark and copyright laws. The correct version of this article can be viewed at https://www.dailypolitical.com/2017/10/19/quorum-health-corporation-qhc-receives-daily-news-sentiment-score-of-0-14.html.

About Quorum Health Corporation

Quorum Health Corporation is an operator and manager of general acute care hospitals and outpatient services in the United States. The Company operates in two segments: Hospital operations, which includes its general acute care hospitals and related healthcare entities that provide inpatient and outpatient healthcare services, and hospital management advisory and consulting services, which includes Quorum Health Resources, LLC (QHR).

Insider Buying and Selling by Quarter for Quorum Health Corporation (NYSE:QHC)

Receive News & Ratings for Quorum Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quorum Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.